The short version
- Why people research itCalm focus, anxiolysis and BDNF support without sedation.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchHeavy drowsiness or confusion.
How Selank works
Anxiolytic/nootropic peptide modulating GABA and serotonin systems and raising BDNF — calm focus without sedation.
Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, printed in exactly those seven residues in the abstract of the paper that first measured what it does to human serum Kost 2001. Read it as two pieces, because that is how it was built: Thr-Lys-Pro-Arg is tuftsin, the immunomodulatory tetrapeptide, and Pro-Gly-Pro is a synthetic tail that does not occur in the parent at all.
What the Pro-Gly-Pro buys, in minutes. It is a protease-resistance device, not decoration, and the number attached to it is small and specific. In rats, the intact heptapeptide is detectable in plasma for 7 to 10 minutes, its half-life exceeds that of other oligopeptides of similar structure, and the main pharmacologically active metabolite is tuftsin itself, Thr-Lys-Pro-Arg Boiko 1998.
- Injectable
- Nasal
On the goal map: BDNF & neurotrophic signaling (Focus, memory & cognition)
Research on Selank5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Russian clinical work in generalized anxiety disorder reported efficacy comparable to benzodiazepines without sedation or dependence, which is the claim that made it interesting and the one most in need of independent replication.
Used intranasally for anxiety and social ease. The consistent report is anxiolysis without cognitive dulling — the opposite of the benzodiazepine trade-off.
How the mechanism reads
A synthetic analog of tuftsin, an immunomodulatory peptide fragment. It is proposed to modulate GABA-A expression indirectly and to affect enkephalin degradation — not to bind the benzodiazepine site, which is the mechanistic basis for the no-dependence claim.
MechanisticIt also raises BDNF, like Semax, which is why the two are commonly paired and why the effect is described as building rather than acute.
Mechanistic
Sources
- Kost NV, Sokolov OY, et al. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorganicheskaia Khimiia 2001 · PMID 11443939
- Zozulya AA, Neznamov GG, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine 2001 · PMID 11550013
- Sokolov OY, et al. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. Bulletin of Experimental Biology and Medicine 2002 · PMID 12432865
- Boiko SS, et al. The pharmacokinetics and metabolism of heptapeptide--a prospective synthetic analog of tuftsin with psychostimulating action in rats. Eksperimentalnaia i Klinicheskaia Farmakologiia 1998 · PMID 9854633
- Zozulia AA, Neznamov GG, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii im S S Korsakova 2008 · PMID 18454096
- Medvedev VE, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii im S S Korsakova 2014 · PMID 25176261
- Medvedev VE, et al. Optimization of the treatment of anxiety disorders with selank. Zhurnal Nevrologii i Psikhiatrii im S S Korsakova 2015 · PMID 26356395
- Volkova A, Shadrina M, et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Frontiers in Pharmacology 2016 · PMID 26924987
- Filatova E, Kasian A, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology 2017 · PMID 28293190
- Vasil'eva EV, et al. Comparison of pharmacological effects of heptapeptide Selank after intranasal and intraperitoneal administration to BALB/c and C57BL/6 mice. Eksperimentalnaia i Klinicheskaia Farmakologiia 2016 · PMID 29787664
- Vyunova TV, Andreeva LA, et al. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters 2018 · PMID 30255741
- Kolik LG, et al. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of Experimental Biology and Medicine 2019 · PMID 31625062
- Konstantinopolsky MA, et al. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bulletin of Experimental Biology and Medicine 2022 · PMID 36322304
- Panikratova YR, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady Biological Sciences 2020 · PMID 32342318
- Kobylyanskii AG, et al. Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells. Bulletin of Experimental Biology and Medicine 2017 · PMID 29063333
- Inozemtseva LS, et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences 2008 · PMID 18841804
- Mjasoedov NF, et al. The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome. Doklady Biological Sciences 2014 · PMID 25371249
Selank safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Benzodiazepine, alcohol or sedative use: Selank modulates GABA and adds to calm.
- Active autoimmune disease: tuftsin analogs alter cytokine balance.
- Pregnancy or breastfeeding: no human data for this tuftsin analog.
- Under 18: tuftsin-analog effects on a developing brain and immune system are untested.
What’s expected
- Calm focus without strong sedation, via GABA, serotonin and BDNF.
- Mild tiredness in some users.
- Occasional soreness where it is applied.
Watch for
- Heavy drowsiness or confusion.
- A rash, itching or swelling.
- Mood flattening that you did not have before.
- Autoimmune symptoms flaring.
Labs that tell you it’s working
- Cortisol
- hs-CRP (C-Reactive Protein, High Sensitivity)
- TNF-Alpha (Tumor Necrosis Factor)
- Comprehensive Metabolic Panel (CMP)
Selank is a tuftsin analog with GABA, serotonin and BDNF effects plus immune modulation; stress hormone and cytokine labs match that mechanism. PMID 25176261 PMID 18454096
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Selank FAQ4 common questions
- Is Selank approved for human use?
- No. Selank is a research compound.
- What is Selank researched for?
- Calm focus, anxiolysis and BDNF support without sedation.
- Which labs show whether it's doing anything?
- Cortisol; hs-CRP; TNF-Alpha; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Selank: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





